FDA approves new drug for bacterial vaginosis

https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209363s000lbl.pdf

The Division of Drug Information (DDI) - serving the public by providing information on human drug products and drug product regulation by FDA.

Today FDA approved a new medication for bacterial vaginosis. This treatment is the first one-dose oral regimen for the most common vaginal infection in women 15-44 years of age.

To learn more, please visit: Solosec.